07 Aug 2024
PANMURE LIBERUM: MaxCyte Inc.: Core in line; Programme revenue ahead
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
PANMURE LIBERUM: MaxCyte Inc.: Core in line; Programme revenue ahead
MaxCyte, Inc. (MXCT:LON) | 299 0 0.0% | Mkt Cap: 314.2m
- Published:
07 Aug 2024 -
Author:
Dr Julie Simmonds | Seb Jantet -
Pages:
12